ID   MYLK2_HUMAN             Reviewed;         596 AA.
AC   Q9H1R3; Q569L1; Q96I84;
DT   19-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   12-OCT-2022, entry version 199.
DE   RecName: Full=Myosin light chain kinase 2, skeletal/cardiac muscle;
DE            Short=MLCK2;
DE            EC=2.7.11.18;
GN   Name=MYLK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND VARIANTS CMH VAL-87 AND GLU-95.
RC   TISSUE=Skeletal muscle;
RX   PubMed=11733062; DOI=10.1016/s0092-8674(01)00586-4;
RA   Davis J.S., Hassanzadeh S., Winitsky S., Lin H., Satorius C., Vemuri R.,
RA   Aletras A.H., Wen H., Epstein N.D.;
RT   "The overall pattern of cardiac contraction depends on a spatial gradient
RT   of myosin regulatory light chain phosphorylation.";
RL   Cell 107:631-641(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Skeletal muscle;
RA   Stanchi F., Lanfranchi G.;
RT   "Full-length sequencing of 100 cDNA clones from human adult skeletal
RT   muscle.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 566-587 IN COMPLEX WITH CENTRIN,
RP   AND SUBUNIT.
RA   Radu L., Miron S., Durand D., Assairi L., Blouquit Y., Charbonnier J.B.;
RT   "Structural features of the complexes formed by Scherffelia dubia
RT   centrin.";
RL   Submitted (JAN-2011) to the PDB data bank.
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-117; VAL-142; ALA-144 AND ASN-324.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Implicated in the level of global muscle contraction and
CC       cardiac function. Phosphorylates a specific serine in the N-terminus of
CC       a myosin light chain. {ECO:0000269|PubMed:11733062}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[myosin light chain] = ADP + H(+) + O-phospho-L-
CC         seryl-[myosin light chain]; Xref=Rhea:RHEA:22004, Rhea:RHEA-
CC         COMP:13684, Rhea:RHEA-COMP:13685, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421,
CC         ChEBI:CHEBI:456216; EC=2.7.11.18;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[myosin light chain] = ADP + H(+) + O-
CC         phospho-L-threonyl-[myosin light chain]; Xref=Rhea:RHEA:53900,
CC         Rhea:RHEA-COMP:13686, Rhea:RHEA-COMP:13687, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977,
CC         ChEBI:CHEBI:456216; EC=2.7.11.18;
CC   -!- SUBUNIT: May interact with centrin. {ECO:0000269|Ref.5}.
CC   -!- INTERACTION:
CC       Q9H1R3; P08238: HSP90AB1; NbExp=3; IntAct=EBI-356910, EBI-352572;
CC       Q9H1R3; Q06413: MEF2C; NbExp=2; IntAct=EBI-356910, EBI-2684075;
CC       Q9H1R3; Q9BYV2: TRIM54; NbExp=2; IntAct=EBI-356910, EBI-2130429;
CC       Q9H1R3; O76024: WFS1; NbExp=3; IntAct=EBI-356910, EBI-720609;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Note=Colocalizes with phosphorylated
CC       myosin light chain (RLCP) at filaments of the myofibrils.
CC   -!- TISSUE SPECIFICITY: Heart and skeletal muscles. Increased expression in
CC       the apical tissue compared to the interventricular septal tissue.
CC   -!- DISEASE: Cardiomyopathy, familial hypertrophic (CMH) [MIM:192600]: A
CC       hereditary heart disorder characterized by ventricular hypertrophy,
CC       which is usually asymmetric and often involves the interventricular
CC       septum. The symptoms include dyspnea, syncope, collapse, palpitations,
CC       and chest pain. They can be readily provoked by exercise. The disorder
CC       has inter- and intrafamilial variability ranging from benign to
CC       malignant forms with high risk of cardiac failure and sudden cardiac
CC       death. {ECO:0000269|PubMed:11733062}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF325549; AAK15494.1; -; mRNA.
DR   EMBL; AJ272502; CAC81354.1; -; mRNA.
DR   EMBL; AL160175; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007753; AAH07753.1; -; mRNA.
DR   EMBL; BC069627; AAH69627.1; -; mRNA.
DR   EMBL; BC092413; AAH92413.1; -; mRNA.
DR   EMBL; BC127622; AAI27623.1; -; mRNA.
DR   CCDS; CCDS13191.1; -.
DR   RefSeq; NP_149109.1; NM_033118.3.
DR   PDB; 2LV6; Other; -; B=566-591.
DR   PDB; 3KF9; X-ray; 2.60 A; B/D=566-587.
DR   PDBsum; 2LV6; -.
DR   PDBsum; 3KF9; -.
DR   AlphaFoldDB; Q9H1R3; -.
DR   BMRB; Q9H1R3; -.
DR   SMR; Q9H1R3; -.
DR   BioGRID; 124494; 85.
DR   IntAct; Q9H1R3; 89.
DR   MINT; Q9H1R3; -.
DR   STRING; 9606.ENSP00000365162; -.
DR   BindingDB; Q9H1R3; -.
DR   ChEMBL; CHEMBL2777; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugBank; DB04825; Prenylamine.
DR   DrugCentral; Q9H1R3; -.
DR   GuidetoPHARMACOLOGY; 1553; -.
DR   iPTMnet; Q9H1R3; -.
DR   PhosphoSitePlus; Q9H1R3; -.
DR   BioMuta; MYLK2; -.
DR   DMDM; 24211884; -.
DR   EPD; Q9H1R3; -.
DR   jPOST; Q9H1R3; -.
DR   MassIVE; Q9H1R3; -.
DR   MaxQB; Q9H1R3; -.
DR   PaxDb; Q9H1R3; -.
DR   PeptideAtlas; Q9H1R3; -.
DR   PRIDE; Q9H1R3; -.
DR   ProteomicsDB; 80445; -.
DR   Antibodypedia; 25246; 154 antibodies from 25 providers.
DR   DNASU; 85366; -.
DR   Ensembl; ENST00000375985.5; ENSP00000365152.4; ENSG00000101306.11.
DR   Ensembl; ENST00000375994.6; ENSP00000365162.2; ENSG00000101306.11.
DR   GeneID; 85366; -.
DR   KEGG; hsa:85366; -.
DR   MANE-Select; ENST00000375985.5; ENSP00000365152.4; NM_033118.4; NP_149109.1.
DR   UCSC; uc002wwq.3; human.
DR   CTD; 85366; -.
DR   DisGeNET; 85366; -.
DR   GeneCards; MYLK2; -.
DR   HGNC; HGNC:16243; MYLK2.
DR   HPA; ENSG00000101306; Tissue enriched (skeletal).
DR   MalaCards; MYLK2; -.
DR   MIM; 192600; phenotype.
DR   MIM; 606566; gene.
DR   neXtProt; NX_Q9H1R3; -.
DR   OpenTargets; ENSG00000101306; -.
DR   Orphanet; 155; NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy.
DR   PharmGKB; PA31389; -.
DR   VEuPathDB; HostDB:ENSG00000101306; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   GeneTree; ENSGT00940000161489; -.
DR   HOGENOM; CLU_000288_90_1_1; -.
DR   InParanoid; Q9H1R3; -.
DR   OMA; PPDPKKD; -.
DR   OrthoDB; 218222at2759; -.
DR   PhylomeDB; Q9H1R3; -.
DR   TreeFam; TF314166; -.
DR   BRENDA; 2.7.11.18; 2681.
DR   PathwayCommons; Q9H1R3; -.
DR   SignaLink; Q9H1R3; -.
DR   SIGNOR; Q9H1R3; -.
DR   BioGRID-ORCS; 85366; 15 hits in 1102 CRISPR screens.
DR   EvolutionaryTrace; Q9H1R3; -.
DR   GeneWiki; MYLK2; -.
DR   GenomeRNAi; 85366; -.
DR   Pharos; Q9H1R3; Tchem.
DR   PRO; PR:Q9H1R3; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9H1R3; protein.
DR   Bgee; ENSG00000101306; Expressed in hindlimb stylopod muscle and 120 other tissues.
DR   Genevisible; Q9H1R3; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0030017; C:sarcomere; IC:BHF-UCL.
DR   GO; GO:0045202; C:synapse; IEA:GOC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; ISS:BHF-UCL.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; ISS:BHF-UCL.
DR   GO; GO:0032027; F:myosin light chain binding; IBA:GO_Central.
DR   GO; GO:0004687; F:myosin light chain kinase activity; IDA:BHF-UCL.
DR   GO; GO:0060048; P:cardiac muscle contraction; IC:BHF-UCL.
DR   GO; GO:0055008; P:cardiac muscle tissue morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; IEA:Ensembl.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0032971; P:regulation of muscle filament sliding; IDA:BHF-UCL.
DR   GO; GO:0035914; P:skeletal muscle cell differentiation; IDA:UniProtKB.
DR   GO; GO:0014816; P:skeletal muscle satellite cell differentiation; IEA:Ensembl.
DR   GO; GO:0006941; P:striated muscle contraction; IDA:BHF-UCL.
DR   CDD; cd14190; STKc_MLCK2; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR042717; MLCK2_STKc.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Calmodulin-binding; Cardiomyopathy;
KW   Cytoplasm; Disease variant; Kinase; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P07313"
FT   CHAIN           2..596
FT                   /note="Myosin light chain kinase 2, skeletal/cardiac
FT                   muscle"
FT                   /id="PRO_0000086408"
FT   DOMAIN          285..540
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..224
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          574..586
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        39..59
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        188..204
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        406
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         291..299
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         314
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P07313"
FT   MOD_RES         143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VCR8"
FT   MOD_RES         149
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VCR8"
FT   MOD_RES         151
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VCR8"
FT   MOD_RES         445
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P20689"
FT   VARIANT         87
FT                   /note="A -> V (in CMH; dbSNP:rs121908107)"
FT                   /evidence="ECO:0000269|PubMed:11733062"
FT                   /id="VAR_014197"
FT   VARIANT         95
FT                   /note="A -> E (in CMH; dbSNP:rs121908108)"
FT                   /evidence="ECO:0000269|PubMed:11733062"
FT                   /id="VAR_014198"
FT   VARIANT         117
FT                   /note="A -> V (in a lung neuroendocrine carcinoma sample;
FT                   somatic mutation; dbSNP:rs1229709568)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040860"
FT   VARIANT         142
FT                   /note="G -> V (in dbSNP:rs56385445)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040861"
FT   VARIANT         144
FT                   /note="P -> A (in dbSNP:rs34396614)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040862"
FT   VARIANT         324
FT                   /note="K -> N (in dbSNP:rs34146416)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040863"
FT   CONFLICT        355..361
FT                   /note="IVLFMEY -> GGVCAHS (in Ref. 4; AAH07753)"
FT                   /evidence="ECO:0000305"
FT   HELIX           567..586
FT                   /evidence="ECO:0007829|PDB:3KF9"
SQ   SEQUENCE   596 AA;  64685 MW;  671A2B5DE9453ADE CRC64;
     MATENGAVEL GIQNPSTDKA PKGPTGERPL AAGKDPGPPD PKKAPDPPTL KKDAKAPASE
     KGDGTLAQPS TSSQGPKGEG DRGGGPAEGS AGPPAALPQQ TATPETSVKK PKAEQGASGS
     QDPGKPRVGK KAAEGQAAAR RGSPAFLHSP SCPAIISSSE KLLAKKPPSE ASELTFEGVP
     MTHSPTDPRP AKAEEGKNIL AESQKEVGEK TPGQAGQAKM QGDTSRGIEF QAVPSEKSEV
     GQALCLTARE EDCFQILDDC PPPPAPFPHR MVELRTGNVS SEFSMNSKEA LGGGKFGAVC
     TCMEKATGLK LAAKVIKKQT PKDKEMVLLE IEVMNQLNHR NLIQLYAAIE TPHEIVLFME
     YIEGGELFER IVDEDYHLTE VDTMVFVRQI CDGILFMHKM RVLHLDLKPE NILCVNTTGH
     LVKIIDFGLA RRYNPNEKLK VNFGTPEFLS PEVVNYDQIS DKTDMWSMGV ITYMLLSGLS
     PFLGDDDTET LNNVLSGNWY FDEETFEAVS DEAKDFVSNL IVKDQRARMN AAQCLAHPWL
     NNLAEKAKRC NRRLKSQILL KKYLMKRRWK KNFIAVSAAN RFKKISSSGA LMALGV
//
